These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26477643)

  • 1. Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension.
    Patel MB; Samuel BP; Girgis RE; Parlmer MA; Vettukattil JJ
    EuroIntervention; 2015 Oct; 11(6):706-9. PubMed ID: 26477643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.
    Rajeshkumar R; Pavithran S; Sivakumar K; Vettukattil JJ
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1145-1153. PubMed ID: 28862384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of a previous atrial septostomy in a patient with end-stage pulmonary hypertension by a manually fenestrated device.
    Baglini R; Scardulla C
    Cardiovasc Revasc Med; 2010; 11(4):264.e9-11. PubMed ID: 20934666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching atrial septal defects in pulmonary hypertension.
    Schwerzmann M; Pfammatter JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):693-701. PubMed ID: 25982879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of five atrial septal communications in the presence of severe pulmonary arterial hypertension and severe left ventricular non-compliance.
    Flaherty MP; Sayfo S; Resar J
    J Invasive Cardiol; 2015 Apr; 27(4):E51-5. PubMed ID: 25840408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.
    Skinner GJ; Tulloh RM; Tometzki AJ; Schulze-Neick I; Morgan GJ
    Cardiol Young; 2013 Oct; 23(5):692-6. PubMed ID: 23089055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy complicated by atrial septal defect and pulmonary hypertension.
    Lim DS; Bergin JD; Ragosta M
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):659-64. PubMed ID: 18360863
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial Septal Defect in a Nonagenarian.
    Żebrowska A; Hryniewiecki T; Stokłosa P; Duchnowski P; Orłowska-Baranowska E; Szymański P
    J Am Geriatr Soc; 2016 Jan; 64(1):224-6. PubMed ID: 26782888
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenestration of a Gore Helex Septal Occluder device in a patient with diastolic dysfunction of the left ventricle.
    Kenny D; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):594-8. PubMed ID: 21384502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
    Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical support for pulmonary veno-occlusive disease: combined atrial septostomy and venovenous extracorporeal membrane oxygenation.
    Hoopes CW; Gurley JC; Zwischenberger JB; Diaz-Guzman E
    Semin Thorac Cardiovasc Surg; 2012; 24(3):232-4. PubMed ID: 23200082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venovenous extracorporeal membrane oxygenation using a single cannula in patients with pulmonary hypertension and atrial septal defects.
    Javidfar J; Brodie D; Sonett J; Bacchetta M
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):982-4. PubMed ID: 22137803
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting.
    Zierer A; Melby SJ; Voeller RK; Moon MR
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H639-44. PubMed ID: 19136607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
    Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
    Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenestrated ASD closure in a child with idiopathic pulmonary hypertension and exercise desaturation.
    Hirsch R; Bagby MC; Zussman ME
    Congenit Heart Dis; 2011; 6(2):162-6. PubMed ID: 21426528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes.
    Lehner A; Schulze-Neick I; Fischer M; Fernandez-Rodriguez S; Ulrich S; Haas NA; Jakob A
    Curr Cardiol Rep; 2019 Mar; 21(5):31. PubMed ID: 30887235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes.
    Talwar S; Keshri VK; Choudhary SK; Gupta SK; Ramakrishnan S; Saxena A; Kothari SS; Juneja R; Kumar G; Airan B
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2570-5. PubMed ID: 24332111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension.
    Olsson KM; Frank A; Fuge J; Welte T; Hoeper MM; Bitter T
    Respir Res; 2015 Nov; 16():137. PubMed ID: 26538143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.